CD1D and Parkinson disease: There were no differences between the patient/control groups in the proportions of B-cell subsets apart from a reduction in CD1d+ (regulatory) B cells in all Parkinson’s disease patients (not just the high-risk group) compared to matched controls (P = 0.017 [paired t-test t(33) = 2.502] (Fig. 3).